Literature DB >> 9306603

Arterial embolization as preoperative treatment for pulmonary aspergillosis with hemoptysis.

Y Otani1, I Yoshida, S Ohki, M Kano, O Kawashima, M Suzuki, Y Sato, T Takahashi, A Ohtaki, S Ishikawa, Y Morishita.   

Abstract

Pulmonary aspergillosis associated with old tuberculosis is generally resistant to treatment. Thus, if patients are treated only with conservative therapy, their condition continues to deteriorate due to repetitive hemoptysis, and may even become critical. Surgical treatment is required for these patients; however, it is extremely difficult to resect the lesion due to severe adhesions to the chest wall and vascular proliferation surrounding the lesion. We performed preoperative arterial embolization, achieving good results in three patients with hemoptysis caused by pulmonary aspergillosis. The feeding arteries were embolized using microcoils and/or gelatin sponges, and a lobectomy was safely carried out in all patients. We concluded that preoperative arterial embolization is a safe and effective technique to prevent massive hemorrhage occurring at the time of surgery.

Entities:  

Mesh:

Year:  1997        PMID: 9306603     DOI: 10.1007/BF02385271

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.540


  13 in total

1.  Pulmonary aspergilloma. Results of surgical treatment.

Authors:  R C Daly; P C Pairolero; J M Piehler; V F Trastek; W S Payne; P E Bernatz
Journal:  J Thorac Cardiovasc Surg       Date:  1986-12       Impact factor: 5.209

2.  Surgery for pulmonary aspergilloma: preoperative embolisation of the bronchial circulation.

Authors:  C F Hughes; R Waugh; D Lindsay
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

3.  [Treatment of hemoptysis by embolization of the systemic circulation].

Authors:  J Rémy; C Voisin; C Dupuis; P Beguery; A B Tonnel; J L Denies; B Douay
Journal:  Ann Radiol (Paris)       Date:  1974 Jan-Feb

4.  Treatment of hemoptysis by embolization of bronchial arteries.

Authors:  J Rémy; A Arnaud; H Fardou; R Giraud; C Voisin
Journal:  Radiology       Date:  1977-01       Impact factor: 11.105

5.  Angiography and therapeutic blockade in the control of hemoptysis. The importance of nonbronchial systemic arteries.

Authors:  I Vujic; R Pyle; G D Hungerford; C N Griffin
Journal:  Radiology       Date:  1982-04       Impact factor: 11.105

6.  Mechanical devices for arterial occlusion.

Authors:  C Gianturco; J H Anderson; S Wallace
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-07

7.  Surgical management of symptomatic pulmonary aspergilloma.

Authors:  J W Battaglini; G F Murray; B A Keagy; P J Starek; B R Wilcox
Journal:  Ann Thorac Surg       Date:  1985-06       Impact factor: 4.330

8.  Bronchial artery embolization in the management of hemoptysis: technical aspects and long-term results.

Authors:  R Uflacker; A Kaemmerer; P D Picon; C F Rizzon; C M Neves; E S Oliveira; M E Oliveira; S N Azevedo; R Ossanai
Journal:  Radiology       Date:  1985-12       Impact factor: 11.105

9.  Ten-year experience with mycetomas in patients with pulmonary tuberculosis.

Authors:  R O Butz; J R Zvetina; B J Leininger
Journal:  Chest       Date:  1985-03       Impact factor: 9.410

10.  Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia.

Authors:  S M Albelda; G H Talbot; S L Gerson; W T Miller; P A Cassileth
Journal:  Am Rev Respir Dis       Date:  1985-01
View more
  2 in total

1.  Arterial embolization to preoperatively manage pulmonary disease associated with inflammation.

Authors:  Tohru Sakuragi; Yukinori Sakao; Masafumi Natsuaki; Tsuyoshi Itoh
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-03

2.  Outcomes of Bronchial Artery Embolization for Life-Threatening Hemoptysis in Patients with Chronic Pulmonary Aspergillosis.

Authors:  Beomsu Shin; Won-Jung Koh; Sung Wook Shin; Byeong-Ho Jeong; Hye Yun Park; Gee Young Suh; Kyeongman Jeon
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.